Literature DB >> 32271459

Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha.

F Zheng1, W Tang, H Li, Y-X Huang, Y-L Xie, Z-G Zhou.   

Abstract

OBJECTIVE: In December 2019, a new type of coronavirus-infected pneumonia broke out in Wuhan and spread rapidly to other parts of the country. The purpose of this study was to investigate the clinical features of coronavirus disease 2019 (COVID-19).
MATERIALS AND METHODS: A retrospective analysis was performed on the confirmed cases of COVID-19, who were admitted to the North Hospital of Changsha first Hospital (Changsha Public Health treatment Center) from January 17 to February 7, 2020.
RESULTS: The median age of COVID-19 patients was 45 years (range 33.5-57). The male patients accounted for 49.7%, 64.6% of the patients had a history of exposure in Wuhan, and 31.7% had family aggregation. The median days of onset were six, and the incidence of severe illness was 18.6%. Compared with the non-severe group, the severe group showed statistical significance in older age, hypertension, bilateral lung plaque shadow, decrease in lymphocyte count, increase in C-reactive protein (CRP), aspartate aminotransferase (AST), lactate dehydrogenase, and creatine kinase.
CONCLUSIONS: Age, combined hypertension, oxygenation index, double lung patch, decreased lymphocyte count, and elevated levels of C-reactive protein, aspartate aminotransferase, lactate dehydrogenase, and creatine kinase can be used as predictors of the disease severity.

Entities:  

Mesh:

Year:  2020        PMID: 32271459     DOI: 10.26355/eurrev_202003_20711

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  90 in total

1.  The Comparison of Sarcopenia Diagnostic Criteria using AWGS 2019 with the Other Five Criteria in West China.

Authors:  Xiaolei Liu; Lisha Hou; Wanyu Zhao; Xin Xia; Fengjuan Hu; Gongchang Zhang; Qiukui Hao; Lixing Zhou; Yixin Liu; Meiling Ge; Yan Zhang; Jirong Yue; Birong Dong
Journal:  Gerontology       Date:  2021-02-17       Impact factor: 5.140

2.  Children with SARS-CoV-2 infection during an epidemic in China (outside of Hubei province).

Authors:  Feifan Xiao; Bin Chen; Tiantian Xiao; Shoo K Lee; Kai Yan; Liyuan Hu
Journal:  Ann Transl Med       Date:  2020-07

Review 3.  Computed tomography findings in 3,557 COVID-19 infected children: a systematic review.

Authors:  Laleh Ebrahimpour; Mahdis Marashi; Hadi Zamanian; Mahboubeh Abedi
Journal:  Quant Imaging Med Surg       Date:  2021-11

4.  Clinical Characteristics and Factors Associated with Disease Progression of Mild to Moderate COVID-19 Patients in a Makeshift (Fangcang) Hospital: A Retrospective Cohort Study.

Authors:  Jia Liu; Jun-Fei Zhang; Han-Ning Ma; Ke Feng; Zhong-Wei Chen; Li-Shan Yang; Bin Mei; Jun-Jian Zhang
Journal:  Ther Clin Risk Manag       Date:  2021-08-16       Impact factor: 2.423

5.  Clinical Manifestations of COVID-19.

Authors:  Mahsa Eskian; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease.

Authors:  Bahareh Gholami; Samira Gholami; Amir Hossein Loghman; Behzad Khodaei; Simin Seyedpour; Nasrin Seyedpour; Amene Saghazadeh; Nima Rezaei
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Hypertension, diabetes mellitus, and cerebrovascular disease predispose to a more severe outcome of COVID-19.

Authors:  Kamleshun Ramphul; Petras Lohana; Yogeshwaree Ramphul; Yun Park; Stephanie Mejias; Balkiranjit Kaur Dhillon; Shaheen Sombans; Renuka Verma
Journal:  Arch Med Sci Atheroscler Dis       Date:  2021-04-12

8.  Effect of comorbid pulmonary disease on the severity of COVID-19: A systematic review and meta-analysis.

Authors:  Askin Gülsen; Inke R König; Uta Jappe; Daniel Drömann
Journal:  Respirology       Date:  2021-05-06       Impact factor: 6.424

9.  Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU

Authors:  Nursel Çalık Başaran; Oğuz Abdullah Uyaroğlu; Gülçin Telli Dizman; Lale Özışık; Taha Koray Şahin; Zahit Taş; Ahmet Çağkan İnkaya; Sevilay Karahan; Şehnaz Alp; Alpaslan Alp; Gökhan Metan; Pınar Zarakol; Gülay Sain Güven; Şerife Gül Öz; Arzu Topeli; Ömrüm Uzun; Murat Akova; Serhat Ünal
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

Review 10.  Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.

Authors:  Nathalie Verónica Fernández Villalobos; Jördis Jennifer Ott; Gérard Krause; Berit Lange; Carolina Judith Klett-Tammen; Annabelle Bockey; Patrizio Vanella
Journal:  Syst Rev       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.